SEARCH

SEARCH BY CITATION

References

  • Agrawal, S., Gupta, S., and Agralwal, A. (2009) Vaccinia virus proteins activate human dendritic cells to induce T cell responses in vitro. Vaccine 27: 8892.
  • Banchereau, J., Briere, F., Caue, C., Davoust, J., Lebecque, S., Liu, Y.J., et al. (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18: 767811.
  • van Beelen, A.J., Zelinkova, Z., Taanman-Kueter, E.W., Muller, F.J., Hommes, D.W., Zaat, S.A., et al. (2007) Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 27: 660669.
  • Bettelli, E., Korn, T., Oukka, M., and Kuchroo, V.K. (2008) Induction and effector functions of T(H)17 cells. Nature 453: 10511057.
  • Cambi, A., Beeren, I., Joosten, B., Fransen, J.A., and Figdor, C.G. (2009) The C-type lectin DC-SIGN internalizes soluble antigens and HIV-1 virions via a clathrin-dependent mechanism. Eur J Immunol 39: 19231928.
  • Dixon, G.L., Newton, P.J., Chain, B.M., Katz, D., Andersen, S.R., Wong, S., et al. (2001) Dendritic cell activation and cytokine production induced by group B Neisseria meningitidis: interleukin-12 production depends on lipopolysaccharide expression in intact bacteria. Infect Immun 69: 43514357.
  • Dyet, K.H., and Martin, D.R. (2005) Sequence variation in the porB gene from B:P1.4 meningococci causing New Zealand's epidemic. J Clin Microbiol 43: 838842.
  • Finne, J., Leinonen, M., and Makela, P.H. (1983) Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet 2: 355357.
  • Fisseha, M., Chen, P., Brandt, B., Kijek, T., Moran, E., and Zollinger, W. (2005) Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccination. Infect Immun 73: 40704080.
  • Fransen, F., Heckenberg, S.G.B., Hamstra, H.J., Feller, M., Boog, C.J.P., van Putten, J.P.M., et al. (2009) Naturally ocurring lipid A mutants in Neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathy. PLoS Pathog 5: e1000396.
  • Gaines Das, R.E., Brugger, P., Patel, M., Mistry, Y., and Poole, S. (2004) Monocyte activation test for pro-inflammatory and pyrogenic contaminants of parenteral drugs: test design and data analysis. J Immunol Methods 288: 165177.
  • Garcia-Vallejo, J., and van Kooyk, Y. (2013) The physiological role of DC-SIGN: a tale of mice and men. Trends Immunol 34: 482486.
  • Geijtenbeek, T.B., Torensma, R., van Vliet, S.J., van Duijnhoven, G.C., Adema, G.J., van Kooyk, Y., and Figdor, C.G. (2000) Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100: 575585.
  • Giuliani, M.M., Adu-Bobie, J., Comanducci, M., Arico, B., Savino, S., Santini, L., et al. (2006) A universal vaccine for serogroup B meningococcus. Proc Natl Acad Sci USA 103: 1083410839.
  • Harrison, L.H. (2006). Vaccine prevention of meningococcal disease: making slow progress. Clin Infect Dis 43: 13951397.
  • Holten, E. (1979) Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six months of 1978. J Clin Microbiol 9: 186188.
  • Hoogerhout, P., Donders, E.M., van Gaans-van den Brink, J.A., Kuipers, B., Bruggee, H.F., van Unen, L.M., et al. (1995) Conjugates of synthetic cyclic peptides elicit bactericidal antibodies against a conformational epitope on a class 1 outer membrane protein of Neisseria meningitidis. Infect Immun 63: 34733478.
  • Jodar, L., Feavers, I.M., Salisbury, D., and Granoff, D.M. (2002) Development of vaccines against meningococcal disease. Lancet 359: 14991508.
  • Jones, C., Virji, M., and Crocker, P.R. (2003) Recognition of sialylated meningococcal lipopolysaccharide by siglecs expressed on myeloid cells leads to enhanced bacterial uptake. Mol Microbiol 49: 12131225.
  • Jones, H.E., Uronen-Hansson, H., Callard, R.E., Klein, N., and Dixon, G.L. (2007) The differential response of human dendritic cells to live and killed Neisseria meningitidis. Cell Microbiol 9: 28562869.
  • Jones, H.E., Strid, J., Osman, M., Uronen-Hansson, H., Dixon, G.L., Klein, N., and Callard, R.E. (2008) The role of beta2 integrins and lipopolysaccharide-binding protein in the phagocytosis of dead Neisseria meningitidis. Cell Microbiol 10: 16341645.
  • de Jong, E.C., Vieira, P.L., Kalinski, P., Schuitemaker, J.H., Tanaka, Y., Wierenga, E.A., et al. (2002) Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse th cell-polarizing signals. J Immunol 168: 17041709.
  • Keiser, P.B., Gibbs, B.T., Coster, T.S., Moran, E.E., Stoddard, M.B., Labrie, J.E., et al. (2010) A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcA. Vaccine 28: 69706976.
  • de Kleijn, E., Van Eijndhoven, L., Vermont, C., Kuipers, B., Van Dijken, H., Rumke, H., et al. (2001) Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine. Vaccine 20: 352358.
  • Koeberling, O., Seubert, A., Santos, G., Colaprico, A., Ugozzoli, M., Donnelly, J., and Granoff, D.M. (2011) Immunogenicity of a meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and over-expressed factor H binding protein in infant rhesus monkeys. Vaccine 29: 47284734.
  • van der Ley, P., and van den Dobbelsteen, G. (2011) Next-generation outer membrane vesicle vaccines against Neisseria meningitidis based on nontoxic LPS mutants. Hum Vaccin 7: 886890.
  • van der Ley, P., Steeghs, L., Hamstra, H.J., ten Hove, J., Zomer, B., and van Alphen, L. (2001) Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity. Infect Immun 69: 59815990.
  • Lucidarme, J., Tan, L., Exley, R.M., Findlow, J., Borrow, R., and Tang, C.M. (2011) Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding protein. Clin Vaccine Immunol 18: 10021014.
  • McAleer, J.P., and Kolls, J.K. (2011) Mechanisms controlling Th17 cytokine expression and host defense. J Leukoc Biol 90: 263270.
  • Martin, D.R., Walker, S.J., Baker, M.G., and Lennon, D.R. (1998) New Zealand epidemic of meningococcal disease identified by a strain with phenotype B:4:P1.4. J Infect Dis 177: 497500.
  • Martin, D.R., Ruijne, N., McCallum, L., O.'Hallahan, J., and Oster, P. (2006) The VR2 epitope on the PorA P1.7-2, 4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB. Clin Vaccine Immunol 13: 438491.
  • Medzhitov, R., Preston-Hurlburt, P., and Janeway, C.A. (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394397.
  • Mesa, C., de Leon, J., Rigley, K., and Fernandez, L.E. (2004) Very small size proteoliposomes derived from Neisseria meningitidis: an effective adjuvant for Th1 induction and dendritic cell activation. Vaccine 22: 30453052.
  • Mittal, R., Bulgheresi, S., Emami, C., and Prasadarao, N. (2009) Enterobacter sakazakii targets DC-SIGN to induce immunosuppressive responses in dendritic cells by modulating MAPKs. J Immunol 183: 65886599.
  • Peck, A., and Mellins, E.D. (2010) Precarious balance: Th17 cells in host defense. Infect Immun 78: 3238.
  • Peiser, L., De Winther, M.P., Makepeace, K., Hollinshead, M., Coull, P., Plested, J., et al. (2002) The class A macrophage scavenger receptor is a major pattern recognition receptor for Neisseria meningitidis which is independent of lipopolysaccharide and not required for secretory responses. Infect Immun 70: 53465354.
  • Pizza, M., Scarlato, V., Masignani, V., Giuliani, M.M., Arico, B., Comanducci, M., et al. (2000) Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287: 18161820.
  • Querec, T., Bennouna, S., Alkan, S., Laouar, Y., Gorden, K., Flavell, R., et al. (2006) Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J Exp Med 203: 413424.
  • Rescigno, M., Martino, M., Sutherland, C.L., Gold, M.R., and Ricciardi-Castagnoli, P. (1998) Dendritic cell survival and maturation are regulated by different signaling pathways. J Exp Med 188: 21752180.
  • Robinson, K., Neal, K., Howard, C., Stockton, J., Atkinson, K., Scarth, E., et al. (2002) Characterization of humoral and cellular immune response elicited by meningococcal carriage. Infect Immun 50: 13011309.
  • Rodenburg, G.D., Fransen, F., Bogaert, D., Schipper, K., Groenwold, R.H., Hamstra, H.J., et al. (2012) Prevalence and clinical course in invasive infections with meningococcal endotoxin variants. PLoS ONE 7: e49295.
  • Rodriguez, T., Perez, O., Menager, N., Ugrinovic, S., Bracho, G., and Mastroeni, P. (2005) Interactions of proteoliposomes from serogroup B Neisseria meningitidis with bone marrow-derived dendritic cells and macrophages: adjuvant effects and antigen delivery. Vaccine 23: 13121321.
  • Sallusto, F., and Lanzavecchia, A. (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179: 11091118.
  • Sareneva, T., Matikainen, S., Kurimoto, M., and Julkunen, I. (1998) Influenza A virus-induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gamma gene expression in human T cells. J Immunol 160: 60326038.
  • Schmitt, C., Villwock, A., and Kurzai, O. (2009) Recognition of meningococcal molecular patterns by innate immune receptors. Int J Med Microbiol 299: 920.
  • Schultz, H., Hume, J., Zhang, D.E.S., Gioannini, T.L., and Weiss, J.P. (2007) A novel role for the bactericidal/permeability increasing protein in interactions of gram-negative bacterial outer membrane blebs with dendritic cells. J Immunol 179: 24772484.
  • Soilleux, E.J., Morris, L.S., Leslie, G., Chehimi, J., Luo, Q., Levroney, E., et al. (2002) Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J Leukoc Biol 71: 445457.
  • Steeghs, L., van Vliet, S.J., Uronen-Hansson, H., van Mourik, A., Eengering, A., Sanchez-Hernandez, M., et al. (2006) Neisseria meningitidis expressing lgtB lipopolysaccharide targets DC-SIGN and modulates dendritic cell function. Cell Microbiol 8: 316325.
  • Steeghs, L., Keestra, A.M., van Mourik, A., Uronen-Hansson, H., van der Ley, P., Callard, R., et al. (2008) Differential activation of human and mouse Toll-like receptor 4 by the adjuvant candidate LpxL1 of Neisseria meningitidis. Infect Immun 76: 38013807.
  • Tacken, P.J., and Figdor, C.G. (2011) Targeted antigen delivery and activation of dendritic cells in vivo: steps towards cost effective vaccines. Semin Immunol 23: 1220.
  • Takeuchi, O., and Akira, S. (2010) Pattern recognition receptors and inflammation. Cell 140: 805820.
  • Toneatto, D., Ismaili, S., Ypma, E., Vienken, K., Oster, P., and Dull, P. (2011) The first use of an investigational multicomponent meningococcal serogroup B vaccine (4CMenB) in humans. Hum Vaccin 7: 646653.
  • Truchetet, M., Beven, L., Renaudin, H., Douchet, I., Ferandon, C., Charron, A., et al. (2011) Potential role of Mycoplasma hominis in interleukin (IL) -17- producing CD4+ T cells generation via induction of IL-23 secretion by human dendritic cells. J Infect Dis 204: 17961805.
  • Ueno, H., Klechevsky, E., Schmitt, N., Ni, L., Flamar, A.L., Zurawski, S., et al. (2011) Targeting human dendritic cell subsets for improved vaccines. Semin Immunol 23: 2127.
  • Uronen-Hansson, H., Steeghs, L., Allen, J., Dixon, G.L., Osman, M., van der Ley, P., et al. (2004) Human dendritic cell activation by Neisseria meningitidis: phagocytosis depends on expression of lipooligosaccharide (LOS) by the bacteria and is required for optimal cytokine production. Cell Microbiol 6: 625637.
  • Xiang, S.D., Scholzen, A., Minigo, G., David, C., Apostolopoulos, V., Mottram, P.L., and Plebanski, M. (2006) Pathogen recognition and development of particulate vaccines: does size matter? Methods 40: 19.
  • Zhou, T., Che, X., Hao, L., and Zhang, Y. (2006) DC-SIGN and immunoregulation. Cell Mol Immunol 3: 279283.